Clinical Trial Update: Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating paclitaxel for vulvar cancer (locally advanced, metastatic, or recurrent) has been completed, providing results from the EORTC s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Cancer

Drugs mentioned

• Taxol (paclitaxel)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Vulvar Cancer | Phase 2 | Status: COMPLETED